arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Myriad Genetics, Inc.

MYGN Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances
$4.57
▼ -2.6% Today
as of Jun 7, 07:22 ET
Last 30 days -5.58% Apr 28 → Jun 05
$3.43 $3.86 $4.29 $4.72 $5.15 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.65
High
$4.71
Low
$4.53
Volume
$1M
Avg Vol
$2M
Mkt Cap
$399M
P/E (TTM)
Beta
52w High
$8.59
52w Low
$3.53
Div Yield
Shares Out
$94M

Overview

52-week range
$3.53
$8.59
21% of range
Avg surprise (last 2)
+8.8%
Avg reaction (last 2)
-1.9%
50% positive
Latest IV / EM
158%
EM ±21.9% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.57$-2.71$-1.85$-1.00$-0.14 Actual $-1.42Actual $-0.75Actual $-0.29Actual $-0.41Actual $-0.24Actual $-0.14Est $-0.17Actual $-3.57Actual $-0.29Actual $-0.16Est $-0.16 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-330M$-248M$-165M$-83M$-105,000 Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.16 $-0.16 0.0% -14.3% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.29 financials
Mon Jun 30, 2025Jun 2025 $-3.57 financials
Tue May 6, 2025Mar/2025 $-0.14 $-0.17 +17.6% -5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.24 financials
Sun Jun 30, 2024Jun 2024 $-0.41 financials
Sun Mar 31, 2024Mar 2024 $-0.29 financials
Sat Sep 30, 2023Sep 2023 $-0.75 financials
Fri Jun 30, 2023Jun 2023 $-1.42 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit$138M$144M$152M$134M$150M$147M
Operating income$-31M$-23M$-329M$-29M$-20M$-36M
Net income$-34M$-27M$-330M$-100,000$-22M$-37M
EPS (diluted)$-0.36$-0.29$-3.57$-0.24$-0.41

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$124M$150M$145M$74M$92M$102M$100M$92M
Inventory$28M$31M$32M$29M$28M$28M$26M$26M
Total current assets$313M$333M$345M$284M$287M$298M$293M$292M
Total assets$674M$707M$728M$677M$1.01B$1.03B$1.08B$1.09B
Long-term debt$120M$120M$120M$0$59M$40M$39M$39M
Total liabilities$336M$339M$355M$289M$301M$326M$350M$345M
Total equity$337M$368M$373M$388M$705M$701M$732M$740M

Implied volatility — last 90 days

152%155%157%160%162% Jun 07 — IV 158% · EM ±21.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.